169 related articles for article (PubMed ID: 36284506)
21. Overcoming Obstacles in Pathological Diagnosis of Pulmonary Nodules through Circulating Tumor Cell Enrichment.
Yin W; Zhu J; Ma B; Jiang G; Zhu Y; He W; Yang Y; Zhang Z
Small; 2020 Jun; 16(25):e2001695. PubMed ID: 32452626
[TBL] [Abstract][Full Text] [Related]
22. A novel application of pulmonary transit time to differentiate between benign and malignant pulmonary nodules using myocardial contrast echocardiography.
Wang B; Sun F; Zheng XZ; Sun CY
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1215-1223. PubMed ID: 33231789
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
[TBL] [Abstract][Full Text] [Related]
24. CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules.
Xu C; Xu X; Shao W; Sun H; Liu X; Feng H; Zuo X; Gao J; Wang G; Yang X; Gu R; Ge S; Wang S; Gao L; Zhu G
Zhongguo Fei Ai Za Zhi; 2023 Jun; 26(6):449-460. PubMed ID: 37488082
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.
Wang W; Liu M; Wang J; Tian R; Dong J; Liu Q; Zhao X; Wang Y
Oncol Res Treat; 2014; 37(12):740-6. PubMed ID: 25531720
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.
Xu L; Su Z; Xie B
J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781
[TBL] [Abstract][Full Text] [Related]
27. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
[TBL] [Abstract][Full Text] [Related]
28. Neural network-based computer-aided diagnosis in distinguishing malignant from benign solitary pulmonary nodules by computed tomography.
Chen H; Wang XH; Ma DQ; Ma BR
Chin Med J (Engl); 2007 Jul; 120(14):1211-5. PubMed ID: 17697569
[TBL] [Abstract][Full Text] [Related]
29. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
Ni LF; Liu XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
[TBL] [Abstract][Full Text] [Related]
31. Value of circulating tumor cells in the diagnosis and treatment of solitary pulmonary nodules.
Liu D; Mao Y; Ma H
Ann Transl Med; 2021 Mar; 9(6):501. PubMed ID: 33850898
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT.
Yuan X; Zhang J; Quan C; Cao J; Ao G; Tian Y; Li H
Eur Radiol; 2013 Sep; 23(9):2469-74. PubMed ID: 23793548
[TBL] [Abstract][Full Text] [Related]
33. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.
Fahrmann JF; Grapov D; DeFelice BC; Taylor S; Kim K; Kelly K; Wikoff WR; Pass H; Rom WN; Fiehn O; Miyamoto S
Cancer Biomark; 2016 Mar; 16(4):609-17. PubMed ID: 27002763
[TBL] [Abstract][Full Text] [Related]
34. Combination diagnosis of multi-slice spiral computed tomography and secretary phospholipase A2-IIa for solitary pulmonary nodules.
Hou H; Xu Z; Zhang H; Xu Y
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493533
[TBL] [Abstract][Full Text] [Related]
35. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
36. Can spectral computed tomography imaging improve the differentiation between malignant and benign pulmonary lesions manifesting as solitary pure ground glass, mixed ground glass, and solid nodules?
Chen ML; Li XT; Wei YY; Qi LP; Sun YS
Thorac Cancer; 2019 Feb; 10(2):234-242. PubMed ID: 30582292
[TBL] [Abstract][Full Text] [Related]
37. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
Suzuki K; Li F; Sone S; Doi K
IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
[TBL] [Abstract][Full Text] [Related]
38. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
[TBL] [Abstract][Full Text] [Related]
39. [Advances and Clinical Application of Malignant Probability Prediction Models for
Solitary Pulmonary Nodule].
Wang Z; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):660-667. PubMed ID: 34455736
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
